Genzyme Thyrogen Diagnostic Co-Promotion Partner Is Knoll
This article was originally published in The Gray Sheet
Executive Summary
Knoll Pharmaceutical will co-promote Genzyme's Thyrogen recombinant thyroid stimulating hormone in the U.S. as a diagnostic agent in the evaluation of thyroid cancer, Genzyme announced Aug. 19.